While EGFR amplification and TP53 mutation, the two prominent genetic alterations, show mutual exclusivity in glioblastoma multiforme (GBM), DNA‐PKcs was found to interact with p53 and inhibit p53 activity. Here, EGFR is linked to glioblastoma.